Companies’ News

Groupize makes The Skift 2018 Corporate Travel Innovators List 5/2

Dev/Con Detect helps get the first ever conviction for theft and money laundering via ad frau. Link to Press release 4/25

MIT Technology Review speaks with Oculogica regarding their groundbreaking Eye-Tracking technology to diagnose concussion 4/25

Congratulations to the outstanding Golden Seeds company Oculogica – and its breakthrough technology for diagnosing concussions – for winning the coveted Luis Villalobos Award for innovation at the Angel Capital Association Summit 4/19

Crimson Hexagon’s Founder and Chair of the Board, Dr. Gary King, Spearheads Groundbreaking Industry-Academic Research Partnership with Facebook.  Link to Press release  4/11

Cognition Therapeutics presenting evidence for Elayta Synaptic Protection in Alzheimer’s Patients at Combined Advances in Alzheimer Therapy and the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders Meeting. Link to Press release 3/14

CEO of Crimson Hexagon, Stephanie Newby,  shares with Forbes the Fear Factors for Women Entrepreneurs 2/28

Zenflow completes Series A round to perform additional clinical studies that will serve to further validate safety and effectiveness of their medical device and to prepare for commercialization 2/18

Tania Yuki, founder and CEO of Shareablee, is featured in CMSWire to discuss her journey and female entrepreneurship 12/17

Congrats to JoyLux raising a funding round and being featured by GeekWire. The company is preparing to launch its medical device product in the U.S.  12/17

Groupize Rolls Out New Automated Hotel-Booking Feature 11/17

Oculogica gets featured in Inno to show how the company is working to change the way brain injuries are diagnosed and defined 11/17

Healthcare Analytics News features Lark’s Weight Loss Health Coach AI to explain how AI can help patients with diabetes lose weight 11/17

Day Zero Diagnostics reduces infectious disease identification time to ensure the correct antibiotic course. PSFK highlights the company’s efforts to tackle the problem of antibiotic resistance 10/17

Cognition Therapeutics receives Fast Track designation from the FDA for their investigational drug for the treatment of patients with Alzheimer’s disease. Link to press release 10/17